Arkolith/Insider Trading/VNDA/Form 4

Polymeropoulos Mihael Hristos

President and CEO, DirectorVanda Pharmaceuticals Inc. (VNDA) · full profile →Form 4 · filed Mar 4, 2025
Net Buying
Open-Market Buys
$47K
Open-Market Sells
$0
Net Open-Market Flow
$47K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 3, 2025Buy(P)10K$4.71$47K2.3M
Mar 1, 2025Tax withholding(F)96K$4.76$457K2.3M

Transaction Codes

P
Open-market purchase
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-032276) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML